default author photo

Sayda Elbashir

Moderna, Inc.

United States

SCHOLARLY PAPERS

1

DOWNLOADS

43

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

mRNA-1273 and Ad26.COV2.S Vaccines Protect Against the B.1.621 Variant of SARS-CoV-2

Number of pages: 41 Posted: 05 Jan 2022
Tamarand Darling, Baoling Ying, Bradley Whitener, Laura A. VanBlargan, Traci Bricker, Chieh-Yu Liang, Astha Joshi, Gayan Bamunuarachchi, kuljeet seehra, Aaron Schmitz, Peter Halfmann, Yoshihiro Kawaoka, Sayda Elbashir, Darin Edwards, Larissa Thackray, Michael S. Diamond and Adrianus Boon
Washington University in St. Louis - Department of Internal Medicine, Washington University in St. Louis - Department of Medicine, Washington University in St. Louis - Department of Internal Medicine, Washington University in St. Louis - Department of Medicine, Washington University in St. Louis - Department of Internal Medicine, Washington University in St. Louis - Department of Pathology and Immunology, Washington University in St. Louis - Department of Medicine, Washington University in St. Louis - Department of Medicine, Washington University in St. Louis - Department of Medicine, Washington University in St. Louis - Division of Immunobiology, University of Wisconsin-Madison - Department of Pathobiological Sciences, University of Wisconsin-Madison - Department of Pathobiological Sciences, Moderna, Inc., Moderna, Inc., Washington University in St. Louis - Department of Medicine, Washington University School of Medicine - Department of Medicine and Washington University in St. Louis - Department of Internal Medicine
Downloads 43 (1,145,425)

Abstract:

Loading...

mRNA-1273, SARS-CoV-2, Ad26.COV2.S, in vivo vaccine efficacy studies, Syrian hamster, mouse